MX2010001730A - Composicion antimicotica. - Google Patents
Composicion antimicotica.Info
- Publication number
- MX2010001730A MX2010001730A MX2010001730A MX2010001730A MX2010001730A MX 2010001730 A MX2010001730 A MX 2010001730A MX 2010001730 A MX2010001730 A MX 2010001730A MX 2010001730 A MX2010001730 A MX 2010001730A MX 2010001730 A MX2010001730 A MX 2010001730A
- Authority
- MX
- Mexico
- Prior art keywords
- antifungally
- antifungal composition
- component
- emulsifying
- independently
- Prior art date
Links
- 239000012871 anti-fungal composition Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describe una composición farmacéutica para administración oral que es auto-emulsionante al hacer contacto con una fase acuosa, en particular fluidos gastrointestinales, y la cual comprende: (a) un compuesto antimicóticamente activo de la fórmula (l) (ver fórmula l) en donde R1, R2 R3 y son independientemente uno del otro hidrógeno, F o Cl; o una sal de adición con ácidos farmacéuticamente aceptables del mismo, y (b) un vehículo que comprende un componente solubilizador para el componente antimicóticamente efectivo (a).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07114652 | 2007-08-21 | ||
| PCT/EP2008/060905 WO2009024590A2 (en) | 2007-08-21 | 2008-08-20 | Antifungal composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010001730A true MX2010001730A (es) | 2010-03-10 |
Family
ID=38656753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010001730A MX2010001730A (es) | 2007-08-21 | 2008-08-20 | Composicion antimicotica. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8536208B2 (es) |
| EP (1) | EP2192893B1 (es) |
| JP (1) | JP5576279B2 (es) |
| KR (1) | KR101493546B1 (es) |
| CN (1) | CN101784259B (es) |
| AU (1) | AU2008290536B2 (es) |
| BR (1) | BRPI0815595B8 (es) |
| CA (1) | CA2697328C (es) |
| ES (1) | ES2551125T3 (es) |
| MX (1) | MX2010001730A (es) |
| PL (1) | PL2192893T3 (es) |
| PT (1) | PT2192893E (es) |
| WO (1) | WO2009024590A2 (es) |
| ZA (1) | ZA201000925B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015502944A (ja) * | 2011-12-02 | 2015-01-29 | コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ | オーラルケア組成物 |
| HUE057773T2 (hu) | 2016-06-20 | 2022-06-28 | Capretto Ehf | Antimikrobiális lipidek stabil kiszerelései |
| CN105943500B (zh) * | 2016-07-08 | 2019-01-04 | 河南省立眼科医院 | 一种含有艾沙康唑的眼用纳米胶束抗真菌溶液 |
| WO2018219804A1 (en) * | 2017-06-02 | 2018-12-06 | Bayer Pharma Aktiengesellschaft | Self-microemulsifying drug delivery systems |
| GB201813229D0 (en) * | 2018-08-14 | 2018-09-26 | Ocutec Ltd | Formulation |
| KR20250008895A (ko) * | 2022-05-12 | 2025-01-16 | 주식회사 지뉴브 | 안정한 액상 제약 제제 |
| WO2025114603A1 (en) | 2023-11-30 | 2025-06-05 | Basilea Pharmaceutica International Ag, Allschwil | Pharmaceutical combinations for use in the treatment of fungal infections |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6054136A (en) | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
| NZ270418A (en) | 1994-02-07 | 1997-09-22 | Eisai Co Ltd | Polycyclic triazole & imidazole derivatives, antifungal compositions |
| WO1999045008A1 (en) | 1998-03-06 | 1999-09-10 | F. Hoffmann-La Roche Ag | 3-[4-(4-cyanophenyl)thiazol-2-y)]-1-(1h-1,2,4-triazol-1-yl)-butan-2-ol derivatives having antifungal activity |
| JP2002513750A (ja) * | 1998-05-07 | 2002-05-14 | エラン コーポレーシヨン ピーエルシー | 溶媒／助溶剤を含まないマイクロエマルジョン及びエマルジョンプレ濃縮物のドラッグデリバリーシステム |
| CA2680292C (en) | 1999-11-02 | 2012-11-27 | Basilea Pharmaceutica Ag | Intermediates useful for the preparation of n-substituted carbamoyloxyalkyl-azolium derivatives |
| JP2001302544A (ja) * | 1999-12-10 | 2001-10-31 | Takeda Chem Ind Ltd | 経口用医薬組成物 |
| US20030072807A1 (en) * | 2000-12-22 | 2003-04-17 | Wong Joseph Chung-Tak | Solid particulate antifungal compositions for pharmaceutical use |
| FR2827770B1 (fr) | 2001-07-27 | 2005-08-19 | Gattefosse Ets Sa | Composition pharmaceutique a usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal |
| US20050186142A1 (en) * | 2002-10-25 | 2005-08-25 | Foamix Ltd. | Kit and composition of imidazole with enhanced bioavailability |
| EP1498123A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Emulsifying systems containing azetidine derivatives |
| FR2861992B1 (fr) * | 2003-11-10 | 2007-07-20 | Sanofi Synthelabo | Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide. |
| JP2007515458A (ja) * | 2003-12-23 | 2007-06-14 | テイボテク・フアーマシユーチカルズ・リミテツド | Ｈｉｖプロテアーゼ阻害剤の自己ミクロ乳化性薬剤送達システム |
| FR2873585B1 (fr) * | 2004-07-27 | 2006-11-17 | Aventis Pharma Sa | Nouvelles formulations galeniques de principes actifs |
| EP1817012A2 (en) * | 2004-11-24 | 2007-08-15 | Merck & Co., Inc. | Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide |
| JP2009510127A (ja) * | 2005-09-29 | 2009-03-12 | リプロス セラピューティクス インコーポレイテッド | ステロイド誘導体および多糖分解されたグリセリドを含む、向上したバイオアベイラビリティーを伴う処方物 |
| ES2581212T3 (es) * | 2005-11-07 | 2016-09-02 | Murty Pharmaceuticals, Inc. | Administración mejorada de tetahidrocannabinol |
-
2008
- 2008-08-20 US US12/674,048 patent/US8536208B2/en active Active
- 2008-08-20 EP EP08787353.5A patent/EP2192893B1/en active Active
- 2008-08-20 WO PCT/EP2008/060905 patent/WO2009024590A2/en active Application Filing
- 2008-08-20 PL PL08787353T patent/PL2192893T3/pl unknown
- 2008-08-20 PT PT87873535T patent/PT2192893E/pt unknown
- 2008-08-20 JP JP2010521419A patent/JP5576279B2/ja active Active
- 2008-08-20 CN CN2008801036395A patent/CN101784259B/zh active Active
- 2008-08-20 BR BRPI0815595A patent/BRPI0815595B8/pt active IP Right Grant
- 2008-08-20 KR KR20107006169A patent/KR101493546B1/ko not_active Expired - Fee Related
- 2008-08-20 AU AU2008290536A patent/AU2008290536B2/en not_active Ceased
- 2008-08-20 MX MX2010001730A patent/MX2010001730A/es active IP Right Grant
- 2008-08-20 ES ES08787353.5T patent/ES2551125T3/es active Active
- 2008-08-20 CA CA2697328A patent/CA2697328C/en active Active
-
2010
- 2010-02-08 ZA ZA201000925A patent/ZA201000925B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5576279B2 (ja) | 2014-08-20 |
| BRPI0815595A8 (pt) | 2018-06-19 |
| BRPI0815595B8 (pt) | 2021-05-25 |
| KR20100064370A (ko) | 2010-06-14 |
| ES2551125T3 (es) | 2015-11-16 |
| PT2192893E (pt) | 2015-11-09 |
| US8536208B2 (en) | 2013-09-17 |
| BRPI0815595B1 (pt) | 2021-02-09 |
| JP2010536826A (ja) | 2010-12-02 |
| US20110281918A1 (en) | 2011-11-17 |
| EP2192893A2 (en) | 2010-06-09 |
| HK1141742A1 (en) | 2010-11-19 |
| AU2008290536A1 (en) | 2009-02-26 |
| BRPI0815595A2 (pt) | 2015-03-03 |
| WO2009024590A2 (en) | 2009-02-26 |
| PL2192893T3 (pl) | 2015-12-31 |
| WO2009024590A3 (en) | 2009-06-04 |
| KR101493546B1 (ko) | 2015-02-16 |
| CN101784259B (zh) | 2013-03-27 |
| EP2192893B1 (en) | 2015-08-19 |
| ZA201000925B (en) | 2010-10-27 |
| AU2008290536B2 (en) | 2012-02-09 |
| CN101784259A (zh) | 2010-07-21 |
| CA2697328A1 (en) | 2009-02-26 |
| CA2697328C (en) | 2015-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN08407A1 (en) | Organic compounds | |
| WO2008142055A3 (en) | Antiviral agents | |
| MX2010001730A (es) | Composicion antimicotica. | |
| TW200744588A (en) | Pharmaceutical composition for external use | |
| UA94065C2 (en) | Dihydropseudoerythromycin derivatives | |
| MX2007010532A (es) | Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii. | |
| TW200833370A (en) | Pharmaceutical composition containing low substituted hydroxypropylcellulose | |
| MX2011012627A (es) | Derivados aminobutiricos sustituidos como inhibidores de nepralisina. | |
| MY153985A (en) | Aminotriazole derivatives as alx agonists | |
| PT2242743E (pt) | Derivados de aminopirazol | |
| MY144209A (en) | Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors | |
| WO2009001060A3 (en) | Use of compounds for preparing anti-tuberculosis agents | |
| WO2007003962A3 (en) | Gpcr agonists | |
| WO2007003961A3 (en) | Gpcr agonists | |
| MY151295A (en) | Pyrimidyl indoline compound | |
| DE602006021539D1 (en) | Morpholine als 5ht2c-agonisten | |
| MX2010009163A (es) | Derivados heterociclicos de urea y metodos de uso de los mismos-211. | |
| WO2009016462A3 (en) | Substituted bicyclolactam compounds | |
| WO2010084115A3 (en) | Antiviral agents | |
| MX2011013771A (es) | Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17. | |
| TW200642689A (en) | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient | |
| NO20083863L (no) | Pyrazoler som 11-beta-hsd-1 | |
| UA105229C2 (uk) | Фармацевтичний склад | |
| IN2012DN03337A (es) | ||
| WO2007099171A3 (en) | Bicyclo-pyrazoles active as kinase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |